Pfizer’s gene therapy for hemophilia A succeeds in late-stage trial

Kena Betancur | Corbis News | Getty ImagesPfizer on Wednesday said its experimental gene therapy for a rare genetic blood-clotting disorder succeeded in a large late-stage trial, paving the way for a potential approval.The treatment for hemophilia A could become the company's second gene therapy to enter the U.S....

Read more...

Lawmakers unveil PBM reform bill amid rising drug costs

Feverpitched | Getty ImagesBipartisan lawmakers introduced a new bill on Tuesday that aims to crack down on the business practices of drug supply chain middlemen who are widely accused of inflating prescription medication prices and harming U.S. patients and pharmacies.The legislation aims to ensure community pharmacies can provide care...

Read more...

Pfizer weight loss pill moves forward as once-daily version

Sopa Images | Lightrocket | Getty ImagesPfizer on Thursday said it will move forward with a once-daily version of its weight loss pill, danuglipron, after it saw "encouraging" data in an ongoing early-stage study. The company evaluated several once-daily formulations of the drug and identified one with "the most...

Read more...

FDA approves Eli Lilly Alzheimer’s drug donanemab

A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana.Scott Olson | Getty ImagesThe Food and Drug Administration on Tuesday approved Eli Lilly's Alzheimer's drug donanemab, expanding the limited treatment options for the mind-wasting disease...

Read more...

Pfizer stock recovers after Covid decline but some employees struggle

Kena Betancur | Corbis News | Getty ImagesPfizer had a "phenomenal" first quarter — and Wall Street took notice, CEO Albert Bourla told thousands of employees during a companywide town hall on May 2, according to a recording heard by CNBC. A day earlier, the pharmaceutical giant's stock had closed...

Read more...

Walgreens (WBA) earnings Q3 2024

In an aerial view, a customer enters a Walgreens store on January 04, 2024 in San Pablo, California. Justin Sullivan | Getty ImagesWalgreens on Thursday reported fiscal third-quarter earnings that fell short of expectations and slashed its full-year adjusted profit outlook, citing a "challenging" environment for pharmacies and U.S. consumers.The...

Read more...

Biden to lower some drug costs through inflation penalties

US President Joe Biden speaks during an event at the National Institutes of Health (NIH) in Bethesda, Maryland, US, on Thursday, Dec. 14 2023. Chris Kleponis | Bloomberg | Getty ImagesThe Biden administration on Wednesday said it will impose inflation penalties on 64 prescription drugs for the third quarter of...

Read more...

Novo Nordisk to boost output of Wegovy, Ozempic with new NC facility

Novo Nordisk's new manufacturing facility in Clayton, North Carolina.Courtesy: Novo NordiskNovo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant in Clayton, North Carolina, in a bid to boost the supply of its blockbuster weight loss drug Wegovy, diabetes treatment Ozempic and other...

Read more...

Eli Lilly expects FDA decision on Zepbound for sleep apnea as early as end of year

Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related breathing disorder and expects regulators to make a decision as early as the end of the year.If cleared by the Food and Drug Administration, the company plans to...

Read more...

FDA approves Merck pneumococcal disease vaccine designed for adults

Zoom In IconArrows pointing outwardsMerck's new pneumococcal vaccine. Courtesy: MerckThe Food and Drug Administration on Monday approved Merck's new vaccine designed to protect adults from a bacteria known as pneumococcus that can cause serious illnesses and a lung infection called pneumonia, the drugmaker said.Merck's shot, called Capvaxive, specifically protects...

Read more...